Factors influencing the success of arterial infusion chemotherapy for cancer of the head and neck.
D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003537:Cystadenoma / Q000188:drug therapy; D004357:Drug Synergism; D005134:Eye Neoplasms / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D007269:Injections, Intra-Arterial; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000532:radiotherapy; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D001761:Bleomycin; D008466:Mechlorethamine; D005472:Fluorouracil; D008727:Methotrexate